Publications by authors named "Boreum Han"

Claim this Profile
R
Rewarding and reinforcing effects of two dissociative-based new psychoactive substances, deschloroketamine and diphenidine, in mice.
Jin Mook Kim, Boreum Han, Hyun Kyu Min, Jaesuk Yun, Young-Hoon Kim

Pharmacol Biochem Behav· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intracellular KRAS-specific antibody enhances the anti-tumor efficacy of gemcitabine in pancreatic cancer by inducing endosomal escape.
Ji Eun Lee, Yeo Wool Kang, Kyung Hee Jung, Mi Kwon Son, Seung-Min Shin, Young-Chan Yoon, Boreum Han, Joo Han Lim

Cancer Lett· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
KRAS targeting antibody synergizes anti-cancer activity of gemcitabine against pancreatic cancer.
Yeo Wool Kang, Ji Eun Lee, Kyung Hee Jung, Mi Kwon Son, Seung-Min Shin, Boreum Han, Joo Han Lim

Cancer Lett· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Melatonin Synergizes with Sorafenib to Suppress Pancreatic Cancer via Melatonin Receptor and PDGFR-β/STAT3 Pathway.
Zhenghuan Fang, Kyung Hee Jung, Hong Hua Yan, Soo-Jung Kim, Marufa Rumman, Boreum Han, Joo Han Lim

Cell Physiol Biochem· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel tropomyosin-related kinase A inhibitor, KK5101 to treat pancreatic cancer.
Zhenghuan Fang, Boreum Han, Kyung Hee Jung, Ju-Hyeon Lee, Ashraf Kareem El-Damasy, Changdev G Gadhe, Gyochang Keum

Cancer Lett· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiosensitization of the PI3K inhibitor HS-173 through reduction of DNA damage repair in pancreatic cancer.
Jung Hee Park, Kyung Hee Jung, Soo Jung Kim, Zhenghuan Fang, Hong Hua Yan, Boreum Han, Joo Han Lim

Oncotarget· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor vessel normalization by the PI3K inhibitor HS-173 enhances drug delivery.
Soo Jung Kim, Kyung Hee Jung, Mi Kwon Son, Jung Hee Park, Hong Hua Yan, Boreum Han, Joo Han Lim

Cancer Lett· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis